Physiomics (PYC LN)

Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.